期刊文献+

基于监测、流行病学和最终结果数据库甲状腺乳头状微癌颈部淋巴结转移的危险因素 被引量:18

Risk Factors of Cervical Lymph Node Metastasis in Papillary Thyroid Microcarcinoma: An Analysis Based on Data from the Surveillance,Epidemiology and End Results Database
暂未订购
导出
摘要 目的通过分析监测、流行病学和最终结果 (SEER)数据库资料,探索甲状腺乳头状微癌(PTMC)淋巴结转移的危险因素。方法回顾性分析2002至2012年SEER数据库中共计31 017例PTMC患者资料,采用Logistic及Cox回归分析探索各因素与PTMC淋巴结转移风险的关联性。结果多因素分析显示,男性(OR=0. 673,95%CI=0. 605~0. 748,P=0. 001)、年龄<55岁(OR=0. 683,95%CI=0. 623~0. 749,P=0. 001)、肿瘤大小> 5 mm (OR=1. 172,95%CI=1. 153~1. 191,P=0. 001)、组织类型为滤泡型(OR=0. 641,95%CI=0. 574~0. 716,P=0. 001)、多灶性(OR=1. 662,95%CI=1. 516~1. 821,P=0. 001)和腺外侵犯(ETE)(包膜侵犯OR=1. 232,95%CI=1. 183~1. 543,P=0. 001,微小侵犯OR=2. 119,95%CI=1. 377~3. 263,P=0. 001,大体侵犯OR=2. 546,95%CI=2. 218~2. 921,P=0. 001)与中央区淋巴结转移显著相关。多因素分析显示,肿瘤大小>5 mm (OR=1. 112,95%CI=1. 091~1. 133,P=0. 001)、男性(OR=0. 36,95%CI=0. 322~0. 401,P=0. 001)、年龄<55岁(OR=0. 503,95%CI=0. 453~0. 559,P=0. 001)、组织类型为滤泡型(OR=0. 625,95%CI=0. 549~0. 711,P=0. 001)、多灶性(OR=2. 265,95%CI=2. 039~2. 517,P=0. 001)、ETE (包膜侵犯OR=2. 105,95%CI=1. 681~2. 637,P=0. 001;微小侵犯OR=4. 601,95%CI=3. 994~5. 300,P=0. 001;大体侵犯OR=7. 093,95%CI=4. 910~10. 246,P=0. 001)及远处转移(OR=11. 948,95%CI=7. 523~18. 975,P=0. 001)与侧颈区淋巴结转移显著相关。结论男性、年轻(<55岁)、肿瘤较大(> 5 mm)、滤泡型PTMC、ETE和多灶性是颈部淋巴结转移的危险因素。远处转移也是侧颈区淋巴结转移的相关因素。对高风险的PTMC患者,推荐行预防性颈部淋巴结清扫术。 Objective To explored the risk factors of lymph node metastasis in papillary thyroid microcarcinoma(PTMC)by analyzing the data from the Surveillance,Epidemiology and End Results(SEER)database.Methods The data of 31 017 patients with PTMC in the SEER database from 2002 to 2012 were retrospectively analyzed.Logistic and Cox regression analyses were used to explore the associations of the factors and the risk of lymph node metastasis in PTMC.Results Multivariate analysis revealed that male(OR=0.673,95%CI=0.605-0.748,P=0.001),age<55 years(OR=0.683,95%CI=0.623-0.749,P=0.001),tumor size>5 mm(OR=1.172,95%CI=1.153-1.191,P=0.001),follicular variant(OR=0.641,95%CI=0.574-0.716,P=0.001),and multifocal(OR=1.662,95%CI=1.516-1.821,P=0.001)and external thyroid extension(ETE)(capsular invasion OR=1.232,95%CI=1.183-1.543,P=0.001;minor invasion OR=2.119,95%CI=1.377-3.263,P=0.001;and gross invasion OR=2.546,95%CI=2.218-2.921,P=0.001)were significantly associated with central lymph node metastasis(CLNM).Multivariate analysis revealed that tumor size>5 mm(OR=1.112,95%CI=1.091-1.133,P=0.001),male(OR=0.36,95%CI=0.322-0.401,P=0.001),age<55 years(OR=0.503,95%CI=0.453-0.559,P=0.001),follicular variant(OR=0.625,95%CI=0.549-0.711,P=0.001),multifocal(OR=2.265,95%CI=2.039-2.517,P=0.001),ETE(capsular invasion OR=2.105,95%CI=1.681-2.637,P=0.001;minor invasion OR=4.601,95%CI=3.994-5.300,P=0.001;and gross invasion OR=7.093,95%CI=4.910-10.246,P=0.001),and distant metastasis(OR=11.948,95%CI=7.523-18.975,P=0.001)were significantly associated with lateral lymph node metastasis.Conclusions Male,young age(<55 years),large tumor(>5 mm),follicular variant-PTMC,ETE,and multifocality are the risk factors for cervical lymph node metastasis.Distant metastasis is associated with lateral lymph node metastasis.For patients at high risk of PTMC,prophylactic neck lymph node dissection is recommended.
作者 郑克思 曾勇 陈聪 吴元肇 陈碧 应文兵 郑克文 ZHENG Kesi;ZENG Yong;CHEN Cong;WU Yuanzhao;CHEN Bi;YING Wenbing;ZHENG Kewen(Department of Oncology,Wenzhou People’s Hospital,the Third Clinical College of Wenzhou Medical University,Wenzhou,Zhejiang 325000,China;Department of Urology,the First Affiliated Hospital of Wenzhou Medical University,the First Clinical College of Wenzhou Medical University,Wenzhou,Zhejiang 325000,China)
出处 《中国医学科学院学报》 CAS CSCD 北大核心 2018年第6期736-743,共8页 Acta Academiae Medicinae Sinicae
基金 温州市公益性科技计划项目(Y20160336 Y20170752) 浙江省自然科学基金(LQ17H050002)~~
关键词 甲状腺乳头状微癌 颈部淋巴结转移 危险因素 papillary thyroid microcarcinoma cervical lymph node metastasis risk factors
  • 相关文献

参考文献3

二级参考文献59

  • 1ZHURui-sen YUYong-li LUHan-kui LUOQuan-yong CHENLi-bo.Clinical study of 312 cases with matastatic differentiated thyroid cancer treated with large doses of ^(131)I[J].Chinese Medical Journal,2005(5):425-428. 被引量:10
  • 2边学,徐震纲,张彬,刘文胜,毛传远,唐平章.分化型甲状腺癌的颈淋巴转移规律[J].中华耳鼻咽喉头颈外科杂志,2006,41(8):599-602. 被引量:67
  • 3American Thyroid Association (ATA) Guidelines Taskforce on Thy- roid Nodules and Differentiated Thyroid Cancer, Cooper DS, Doherty GM, et al. Revised American thyroid association manage- ment guidelines for patients with thyroid nodules and differentiat- ed thyroid cancer[J]. Thyroid, 2009, 19(11):1167-1214.
  • 4Haugen BR, Alexander EK, Bible KC, et al. 2015 American thyroid as- sociation management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid as- sociation guidelines task force on thyroid nodules and differentiat- ed thyroid cancer[J]. Thyroid, 2016, 26(1):1-133.
  • 5Tuttle RM, Haddad RI, Ball DW, et al. Thyroid carcinoma, version 2.2014[J]. J Natl Compr Canc Netw, 2014, 12(12):1671-1680.
  • 6Xing MZ. Molecular pathogenesis and mechanisms of thyroid can- cer[J]. Nat Rev Cancer, 2013, 13(3):184-199.
  • 7De Biase D, Gandolfi G, Ragazzi M, et al. TERT promoter mutations in papillary thyroid microcarcinomas[J]. Thyroid, 2015, 25(9):1013- 1019.
  • 8Ito Y, Miyauchi A, Inoue H, et al. An observational trial for papillary thyroid microcarcinoma in Japanese patients[J]. World J Surg, 2010, 34(1):28-35.
  • 9Ito Y, Uruno T, Nakano K, et al. An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid [J]. Thyroid, 2003, 13(4):381-387.
  • 10Xing M, Alzahrani AS, Carson KA, et al. Association between BRAF V600E mutation and recurrence of papillary thyroid cancer[J]. J Clin Oncol, 2015, 33(1):42-50.

共引文献1311

同被引文献171

引证文献18

二级引证文献142

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部